INmune Bio Inc. to Report Second Quarter 2026 Financial Results and Provide Corporate Update on Thursday, August 6th
Go back to INmune Bio Inc. to Report Second Quarter 2026 Financial Results and Provide Corporate Update on Thursday, August 6th| (NASDAQ: INMB) | Delayed: 2.44 +0.17 (7.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.27 | 52 Week High | $ | |||
| Open | $2.27 | 52 Week Low | $ | |||
| Day High | $2.45 | P/E | N/A | |||
| Day Low | $2.22 | EPS | $ | |||
| Volume | 323,962 | |||||
| (NASDAQ: INMB) | Delayed: 2.44 +0.17 (7.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.27 | 52 Week High | $ | |||
| Open | $2.27 | 52 Week Low | $ | |||
| Day High | $2.45 | P/E | N/A | |||
| Day Low | $2.22 | EPS | $ | |||
| Volume | 323,962 | |||||

